Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development

Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development

Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by progressive degeneration of retinal photoreceptors leading to progressive visual decline. It is the most common type of inherited retinal dystrophy and has a high burden on both patients and society. This cond...

Full description

Bibliographic Details
Main Authors: Kevin Y. Wu, Merve Kulbay, Dana Toameh, An Qi Xu, Ananda Kalevar, Simon D. Tran
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
retinitis pigmentosa
ER stress
retinal degeneration
photoreceptor cell death
therapeutic target
neuroprotection
Online Access:https://www.mdpi.com/1999-4923/15/2/685

Internet

https://www.mdpi.com/1999-4923/15/2/685

Similar Items